CLINICAL ROLE -
The Effect of Pharmacist Intervention on Hospitalization Rates in Older Adults With Epilepsy
Comorbidities and cognitive impairment worsen non-adherence to anti-seizure medications in older adults.
Oncology Overview: Atezolizumab (Tecentriq)
Since its initial approval in 2016 for urothelial carcinoma, atezolizumab has received FDA approval for an additional 5 types of carcinomas.
Clinical Insights: Axicabtagene Ciloleucel (Yescarta)
Axicabtagene ciloleucel (Yescarta) was the first CAR T-cell immunotherapy to be approved for relapsed or refractory large B-cell lymphoma.
2 Clarke Drive Cranbury, NJ 08512